Lipoprotein(a) variability over time in adult lipid clinic patients
Lipoprotein(a) (Lp[a]) is a low-density lipoprotein (LDL)-like particle in which apolipoprotein (apo) B is covalently bound to a plasminogen-like molecule called apo(a) [1]. Elevated plasma Lp(a) concentration is an independent risk factor for atherosclerotic cardiovascular disease (ASCVD), including myocardial infarction, stroke and cardiac death [1]. The European Atherosclerosis Society, European Society of Cardiology and Canadian Cardiovascular Society (CCS) dyslipidemia guidelines recommend measurement of Lp(a) once in an individual's lifetime to identify patients with high levels who would benefit from earlier, more intensive health behaviour modification and management of ASCVD risk [2,3].
Source: Atherosclerosis - Category: Cardiology Authors: Isabel Shamsudeen, Robert A. Hegele Tags: Correspondence Source Type: research